Pyrosequencing s Q4 Revenues Jump on Sales of PSQ Sequencing System | GenomeWeb

NEW YORK, Feb 22 - Pyrosequencing, a manufacturer of DNA sequencing equipment based in Uppsala, Sweden, reported Thursday fourth quarter revenes ot $2.7 million, compared with $116,525 million in the year ago period, due to sales of the company's flagship product, the PSQ 96 DNA sequencing system.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CBC Marketplace commissions DNA testing of chicken sandwiches at Subway and other fast-food chains.

In a speech to Congress, President Donald Trump called the drug approval process at FDA "slow and burdensome."

In Genome Research this week: algorithm to tease out strains from metagenomic sequences, drug resistance mechanisms in cancer cells, and more.

Variants in the IFITM3 gene affect inflammatory response to infection, UPI reports.